News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
99 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (22869)
Month
January (2433)
February (2868)
March (3029)
April (3116)
May (3356)
June (2727)
July (2287)
August (2493)
September (560)
Day
2 (21)
3 (134)
4 (182)
5 (180)
6 (173)
7 (76)
9 (47)
10 (146)
11 (152)
12 (92)
13 (139)
14 (94)
16 (32)
17 (75)
18 (119)
19 (85)
20 (105)
21 (27)
23 (16)
24 (91)
25 (102)
26 (99)
27 (116)
28 (49)
30 (27)
31 (114)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
Day
2
3
4
5
6
7
9
10
11
12
13
14
16
17
18
19
20
21
23
24
25
26
27
28
30
31
Manufacturing
Vitruvias vanishes amid thyroid tablets recall over potential ‘superpotency’ concerns
Vitruvias Therapeutics has “ceased operations” after voluntarily recalling a batch recall of generic thyroid tablets due to possible superpotency that could cause a range of adverse events.
August 26, 2026
·
2 min read
·
Nick Paul Taylor
Press Releases
Patients Representing the Power of Advanced Therapies to Take Center Stage at Emily Whitehead Foundation’s 2026 Believe Ball
August 26, 2026
·
4 min read
Press Releases
Channel Methods Launches MethodsSignals for Life Sciences Business Development
Formulated Solutions reports a more than 90% reduction in time from market insight to customer outreach.
August 26, 2026
·
1 min read
Press Releases
AIVITA Biomedical Publishes a Universal Dendritic Cell Cancer Vaccine Platform
August 26, 2026
·
4 min read
Press Releases
Roche receives FDA approval for companion diagnostic tests to identify patients with HER2-positive metastatic gastroesophageal adenocarcinoma eligible for ZIIHERA
August 26, 2026
·
6 min read
Press Releases
First Tracks Biotherapeutics Announces Participation in September 2026 Investor Conferences
August 26, 2026
·
1 min read
Press Releases
RxSight, Inc. to Participate in the Wells Fargo Healthcare Conference 2026
August 26, 2026
·
1 min read
Press Releases
Vaxart Expands Intellectual Property Portfolio with European Patent Protecting Proprietary Norovirus Vaccine Technology
August 26, 2026
·
6 min read
Press Releases
Interpace Biosciences Announces Reverse Stock Split to Support Proposed Nasdaq Uplisting
August 26, 2026
·
5 min read
Press Releases
Xenon to Highlight Phase 3 X-TOLE2 Clinical Data and Rational Polytherapy Potential for Azetukalner at EEC 2026
August 26, 2026
·
9 min read
Previous
9 of 10
Next
